Lee Hambright
Stock Analyst at Bernstein
(3.38)
# 982
Out of 5,055 analysts
27
Total ratings
75%
Success rate
10.03%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Market Perform | $172 → $193 | $195.93 | -1.50% | 5 | Oct 6, 2025 | |
| MDT Medtronic | Maintains: Outperform | $97 → $98 | $95.87 | +2.22% | 3 | Aug 20, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $138 → $144 | $130.59 | +10.27% | 5 | Apr 17, 2025 | |
| PODD Insulet | Initiates: Outperform | $300 | $332.70 | -9.83% | 1 | Nov 6, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Outperform | $42 | $18.61 | +125.69% | 1 | Nov 6, 2024 | |
| DXCM DexCom | Maintains: Outperform | $82 → $86 | $58.06 | +48.12% | 2 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $92 → $100 | $102.69 | -2.62% | 1 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $350 → $365 | $549.51 | -33.58% | 2 | May 31, 2023 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $136 → $152 | $89.91 | +69.06% | 1 | May 3, 2023 | |
| SYK Stryker | Upgrades: Outperform | $288 → $295 | $362.22 | -18.56% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $86.30 | +56.43% | 3 | Mar 16, 2022 |
Johnson & Johnson
Oct 6, 2025
Maintains: Market Perform
Price Target: $172 → $193
Current: $195.93
Upside: -1.50%
Medtronic
Aug 20, 2025
Maintains: Outperform
Price Target: $97 → $98
Current: $95.87
Upside: +2.22%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $138 → $144
Current: $130.59
Upside: +10.27%
Insulet
Nov 6, 2024
Initiates: Outperform
Price Target: $300
Current: $332.70
Upside: -9.83%
Tandem Diabetes Care
Nov 6, 2024
Initiates: Outperform
Price Target: $42
Current: $18.61
Upside: +125.69%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $82 → $86
Current: $58.06
Upside: +48.12%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $102.69
Upside: -2.62%
Intuitive Surgical
May 31, 2023
Maintains: Outperform
Price Target: $350 → $365
Current: $549.51
Upside: -33.58%
Zimmer Biomet Holdings
May 3, 2023
Maintains: Market Perform
Price Target: $136 → $152
Current: $89.91
Upside: +69.06%
Stryker
Mar 16, 2022
Upgrades: Outperform
Price Target: $288 → $295
Current: $362.22
Upside: -18.56%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $86.30
Upside: +56.43%